tiprankstipranks
Trending News
More News >
TME Pharma N.V. (DE:0N6A)
:0N6A
Germany Market

TME Pharma N.V. (0N6A) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
13Bullish
6Neutral
2Bearish
Technical Analysis Consensus
Buy
3Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
1Neutral
1Bearish
TME Pharma N.V.’s (0N6A) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting TME Pharma N.V. is a Buy.
TME Pharma N.V.’s (0N6A) 20-Day exponential moving average is 0.08, while TME Pharma N.V.’s (0N6A) share price is <€0.1, making it a Buy.
TME Pharma N.V.’s (0N6A) 50-Day exponential moving average is 0.07, while TME Pharma N.V.’s (0N6A) share price is <€0.1, making it a Buy.

TME Pharma N.V. (0N6A) Pivot Points

Jun 16, 2025, 10:16 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.07
0.07
0.08
0.08
0.08
0.08
0.09
Fibonacci
0.07
0.08
0.08
0.08
0.08
0.08
0.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

TME Pharma N.V. (0N6A) Moving Averages

Jun 16, 2025, 10:16 PM
Period
Simple
Exponential
MA5
0.08Buy
0.08Buy
MA10
0.08Neutral
0.08Buy
MA20
0.08Buy
0.08Buy
MA50
0.07Buy
0.07Buy
MA100
0.07Buy
0.07Buy
MA200
0.08Buy
0.08Sell
TME Pharma N.V.’s (0N6A) 10-Day exponential moving average is 0.08, while TME Pharma N.V.’s (0N6A) share price is <€0.1, making it a Buy.
TME Pharma N.V.’s (0N6A) 100-Day exponential moving average is 0.07, while TME Pharma N.V.’s (0N6A) share price is <€0.1, making it a Buy.
TME Pharma N.V.’s (0N6A) stock price is <€0.1 and TME Pharma N.V.’s (0N6A) 50-day simple moving average is 0.07, creating a Buy signal.
TME Pharma N.V.’s (0N6A) stock price is <€0.1 and TME Pharma N.V.’s (0N6A) 100-day simple moving average is 0.07, creating a Buy signal.
TME Pharma N.V.’s (0N6A) stock price is <€0.1 and TME Pharma N.V.’s (0N6A) 200-day simple moving average is 0.08, creating a Buy signal.

TME Pharma N.V. (0N6A) Technical Indicators

Jun 16, 2025, 10:16 PM
Name
Value
Implied Action
RSI (14)
65.91
Neutral
STOCH (9,6)
37.06
Neutral
STOCHRSI (14)
16.07
Buy
MACD (12,26)
<0.01
Buy
ADX (14)
41.09
Neutral
Williams %R
-83.93
Buy
CCI (14)
-17.19
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
66.18
Neutral
ROC
0.00
Buy
TME Pharma N.V.’s (0N6A) Relative Strength Index (RSI) is 65.91, creating a Neutral signal.
TME Pharma N.V.’s (0N6A) Trend Strength Indicator (ADX) is 41.09, creating a Neutral signal.
TME Pharma N.V.’s (0N6A) Commodity Channel Index (CCI) is -17.19, creating a Neutral signal.

FAQ

Is 0N6A a Buy, Hold, or Sell?
Based on 0N6A’s technical indicators, 0N6A is a Strong Buy.
    What is 0N6A’s RSI (14)?
    0N6A’s RSI (14) is 65.91, which suggests 0N6A is a Neutral.
      What is 0N6A’s MACD?
      0N6A’s MACD is <0.01, which suggests 0N6A is a Buy.
        What is 0N6A’s 5-day moving average?
        0N6A’s 5-day moving average is 0.08, which suggests 0N6A is a Buy.
          What is 0N6A’s 20-day moving average?
          0N6A 20-day moving average is 0.08, which suggests 0N6A is a Buy.
            What is 0N6A’s 50-day moving average?
            0N6A’s 50-day moving average is 0.07, which suggests 0N6A is a Buy.
              What is 0N6A’s 200-day moving average?
              0N6A’s 200-day moving average is 0.08, which suggests 0N6A is a Buy.
                What is 0N6A’s Williams % R (14)?
                0N6A’s Williams % R (14) is -83.93, which suggests 0N6A is a Buy.
                  What is 0N6A’s CCI (14)?
                  0N6A’s CCI (14) is -17.19, which suggests 0N6A is a Neutral.
                    What is the share price of TME Pharma N.V.?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis